Filing Details
- Accession Number:
- 0001576885-23-000052
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-08-18 18:31:27
- Reporting Period:
- 2023-08-17
- Accepted Time:
- 2023-08-18 18:31:27
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1576885 | Acumen Pharmaceuticals Inc. | ABOS | Biological Products, (No Disgnostic Substances) (2836) | 364108129 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1614096 | L. Jeffrey Ives | C/O Acumen Pharmaceuticals, Inc. 427 Park Street Charlottesville VA 22902 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2023-08-17 | 39,149 | $0.72 | 39,149 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2023-08-17 | 39,149 | $6.48 | 0 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2023-08-17 | 2,800 | $1.19 | 2,800 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2023-08-17 | 2,800 | $6.66 | 0 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | Disposition | 2023-08-17 | 39,149 | $0.00 | 39,149 | $0.72 |
| Common Stock | Stock Option (right to buy) | Disposition | 2023-08-17 | 2,800 | $0.00 | 2,800 | $1.19 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2029-03-01 | No | 4 | M | Direct | |
| 0 | 2031-01-03 | No | 4 | M | Direct |
Footnotes
- The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on May 17, 2023.
- The option is fully vested.
Billionaire Hedge Funds
